Sep 11, 2019 / 01:20PM GMT
Unidentified Analyst -
Good morning, everyone. Thank you for being here. I'm pleased to introduce Eagle Pharmaceuticals this morning. From the company, we have Scott Tarriff, the CEO; as well as Pete Meyers, the CFO. So thank you both for joining us this morning.
Scott L. Tarriff - Eagle Pharmaceuticals, Inc. - CEO & Director
Thank you for having us.
Questions and Answers:
Unidentified Analyst -Perhaps, firstly, we can start with an update on the business overall. Obviously, a number of important milestones and outcomes for you in the first half of the year, so it would be great to get an update from you guys.
Scott L. Tarriff - Eagle Pharmaceuticals, Inc. - CEO & Director
Yes. I would be pleased. Thank you, again, for having us here. Thanks for everybody who are attending. I think as you look to the future of Eagle, it's really a story about our pipeline, where we're a profitable company, we have a lot of cash, we don't have any debt. We don't have a number of the concerns
Trustpilot
